Say NO to Novartis!March 19, 2012 Novartis, the Swiss-based pharmaceutical giant, continues its assault on India's generic pharmaceutical industry -- legally challenging India's patent law that allows the nation to supply nearly 80% of the developing world's access to high-quality, affordable, life-saving medications. India's patent law effectively stops evergreening, a tactic used by pharmaceutical companies to make minor tweaks on medications to extend their stranglehold on a patent that is about to expire. Should Novartis succeed on March 28th, a dangerous precedent will be set ... With a chain-reaction of serious consequences. View Full Article Visit HIV Prevention Justice Alliance's website to find out more about their activities and publications.
Comment by: michael
(los angeles)
Sat., Mar. 24, 2012 at 5:43 am EDT and yet more proof that HIV is a profitable business. big pharma doesn't want to kill us, they want to kill us slowly. they don't want to cure us, there is no profit in it. curing us is the same as killing us.....no profit. wake up people. these people have deep pockets to pay off every single vote and influential people to turn a blind eye. DON'T TREAT US. CURE US!
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|